MedTrace Logo

Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection

NCT02329821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2015-07-13

No results posted yet for this study

Summary

The investigators are trying to investigate metabolism of lactate sourced from IV Hartmann's solution in patients with hepatocellular carcinoma(HCC) compared with a control group(donation for liver transplantation) with normal liver function. Second purpose of this study is finding the predictive factor of changing metabolism of lactate sourced from IV Hartmann's solution in patients with HCC.

Conditions

Interventions

OTHER

hartmann solution

hartmann solution infusion in patients for hepatic resection

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Gaab Soo Kim, M.D, Ph.D · Samsung Medical Center

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02329821 on ClinicalTrials.gov